<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE LCTL_TEXT SYSTEM "ltf.v1.5.dtd">
<LCTL_TEXT lang="spa">
<DOC id="L0C04CVO6" lang="spa" tokenization="tokenization_parameters.v5.0" grammar="none" raw_text_char_length="1621" raw_text_md5="8b1435ae40a8abb7e107485510d5f6c0">
<TEXT>
<SEG id="segment-0" start_char="1" end_char="62">
<ORIGINAL_TEXT>Interferon-α2b May Shorten Viral Shedding Duration in COVID-19</ORIGINAL_TEXT>
<TOKEN id="token-0-0" pos="unknown" morph="none" start_char="1" end_char="14">Interferon-α2b</TOKEN>
<TOKEN id="token-0-1" pos="word" morph="none" start_char="16" end_char="18">May</TOKEN>
<TOKEN id="token-0-2" pos="word" morph="none" start_char="20" end_char="26">Shorten</TOKEN>
<TOKEN id="token-0-3" pos="word" morph="none" start_char="28" end_char="32">Viral</TOKEN>
<TOKEN id="token-0-4" pos="word" morph="none" start_char="34" end_char="41">Shedding</TOKEN>
<TOKEN id="token-0-5" pos="word" morph="none" start_char="43" end_char="50">Duration</TOKEN>
<TOKEN id="token-0-6" pos="word" morph="none" start_char="52" end_char="53">in</TOKEN>
<TOKEN id="token-0-7" pos="unknown" morph="none" start_char="55" end_char="62">COVID-19</TOKEN>
</SEG>
<SEG id="segment-1" start_char="67" end_char="266">
<ORIGINAL_TEXT>FRIDAY, May 15, 2020 (HealthDay News) -- Interferon (IFN)-α2b therapy seems to shorten the duration of viral shedding in hospitalized COVID-19 patients, according to a study published online May 15 in</ORIGINAL_TEXT>
<TOKEN id="token-1-0" pos="word" morph="none" start_char="67" end_char="72">FRIDAY</TOKEN>
<TOKEN id="token-1-1" pos="punct" morph="none" start_char="73" end_char="73">,</TOKEN>
<TOKEN id="token-1-2" pos="word" morph="none" start_char="75" end_char="77">May</TOKEN>
<TOKEN id="token-1-3" pos="word" morph="none" start_char="79" end_char="80">15</TOKEN>
<TOKEN id="token-1-4" pos="punct" morph="none" start_char="81" end_char="81">,</TOKEN>
<TOKEN id="token-1-5" pos="word" morph="none" start_char="83" end_char="86">2020</TOKEN>
<TOKEN id="token-1-6" pos="punct" morph="none" start_char="88" end_char="88">(</TOKEN>
<TOKEN id="token-1-7" pos="word" morph="none" start_char="89" end_char="97">HealthDay</TOKEN>
<TOKEN id="token-1-8" pos="word" morph="none" start_char="99" end_char="102">News</TOKEN>
<TOKEN id="token-1-9" pos="punct" morph="none" start_char="103" end_char="103">)</TOKEN>
<TOKEN id="token-1-10" pos="punct" morph="none" start_char="105" end_char="106">--</TOKEN>
<TOKEN id="token-1-11" pos="word" morph="none" start_char="108" end_char="117">Interferon</TOKEN>
<TOKEN id="token-1-12" pos="punct" morph="none" start_char="119" end_char="119">(</TOKEN>
<TOKEN id="token-1-13" pos="unknown" morph="none" start_char="120" end_char="127">IFN)-α2b</TOKEN>
<TOKEN id="token-1-14" pos="word" morph="none" start_char="129" end_char="135">therapy</TOKEN>
<TOKEN id="token-1-15" pos="word" morph="none" start_char="137" end_char="141">seems</TOKEN>
<TOKEN id="token-1-16" pos="word" morph="none" start_char="143" end_char="144">to</TOKEN>
<TOKEN id="token-1-17" pos="word" morph="none" start_char="146" end_char="152">shorten</TOKEN>
<TOKEN id="token-1-18" pos="word" morph="none" start_char="154" end_char="156">the</TOKEN>
<TOKEN id="token-1-19" pos="word" morph="none" start_char="158" end_char="165">duration</TOKEN>
<TOKEN id="token-1-20" pos="word" morph="none" start_char="167" end_char="168">of</TOKEN>
<TOKEN id="token-1-21" pos="word" morph="none" start_char="170" end_char="174">viral</TOKEN>
<TOKEN id="token-1-22" pos="word" morph="none" start_char="176" end_char="183">shedding</TOKEN>
<TOKEN id="token-1-23" pos="word" morph="none" start_char="185" end_char="186">in</TOKEN>
<TOKEN id="token-1-24" pos="word" morph="none" start_char="188" end_char="199">hospitalized</TOKEN>
<TOKEN id="token-1-25" pos="unknown" morph="none" start_char="201" end_char="208">COVID-19</TOKEN>
<TOKEN id="token-1-26" pos="word" morph="none" start_char="210" end_char="217">patients</TOKEN>
<TOKEN id="token-1-27" pos="punct" morph="none" start_char="218" end_char="218">,</TOKEN>
<TOKEN id="token-1-28" pos="word" morph="none" start_char="220" end_char="228">according</TOKEN>
<TOKEN id="token-1-29" pos="word" morph="none" start_char="230" end_char="231">to</TOKEN>
<TOKEN id="token-1-30" pos="word" morph="none" start_char="233" end_char="233">a</TOKEN>
<TOKEN id="token-1-31" pos="word" morph="none" start_char="235" end_char="239">study</TOKEN>
<TOKEN id="token-1-32" pos="word" morph="none" start_char="241" end_char="249">published</TOKEN>
<TOKEN id="token-1-33" pos="word" morph="none" start_char="251" end_char="256">online</TOKEN>
<TOKEN id="token-1-34" pos="word" morph="none" start_char="258" end_char="260">May</TOKEN>
<TOKEN id="token-1-35" pos="word" morph="none" start_char="262" end_char="263">15</TOKEN>
<TOKEN id="token-1-36" pos="word" morph="none" start_char="265" end_char="266">in</TOKEN>
</SEG>
<SEG id="segment-2" start_char="269" end_char="291">
<ORIGINAL_TEXT>Frontiers in Immunology</ORIGINAL_TEXT>
<TOKEN id="token-2-0" pos="word" morph="none" start_char="269" end_char="277">Frontiers</TOKEN>
<TOKEN id="token-2-1" pos="word" morph="none" start_char="279" end_char="280">in</TOKEN>
<TOKEN id="token-2-2" pos="word" morph="none" start_char="282" end_char="291">Immunology</TOKEN>
</SEG>
<SEG id="segment-3" start_char="294" end_char="294">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN id="token-3-0" pos="punct" morph="none" start_char="294" end_char="294">.</TOKEN>
</SEG>
<SEG id="segment-4" start_char="297" end_char="559">
<ORIGINAL_TEXT>Qiong Zhou, M.D., Ph.D., from the Union Hospital Tongji Medical College and Huazhong University of Science and Technology in Wuhan, China, and colleagues describe the effects of treatment with IFN-α2b in a cohort of 77 adults hospitalized with confirmed COVID-19.</ORIGINAL_TEXT>
<TOKEN id="token-4-0" pos="word" morph="none" start_char="297" end_char="301">Qiong</TOKEN>
<TOKEN id="token-4-1" pos="word" morph="none" start_char="303" end_char="306">Zhou</TOKEN>
<TOKEN id="token-4-2" pos="punct" morph="none" start_char="307" end_char="307">,</TOKEN>
<TOKEN id="token-4-3" pos="unknown" morph="none" start_char="309" end_char="311">M.D</TOKEN>
<TOKEN id="token-4-4" pos="punct" morph="none" start_char="312" end_char="313">.,</TOKEN>
<TOKEN id="token-4-5" pos="unknown" morph="none" start_char="315" end_char="318">Ph.D</TOKEN>
<TOKEN id="token-4-6" pos="punct" morph="none" start_char="319" end_char="320">.,</TOKEN>
<TOKEN id="token-4-7" pos="word" morph="none" start_char="322" end_char="325">from</TOKEN>
<TOKEN id="token-4-8" pos="word" morph="none" start_char="327" end_char="329">the</TOKEN>
<TOKEN id="token-4-9" pos="word" morph="none" start_char="331" end_char="335">Union</TOKEN>
<TOKEN id="token-4-10" pos="word" morph="none" start_char="337" end_char="344">Hospital</TOKEN>
<TOKEN id="token-4-11" pos="word" morph="none" start_char="346" end_char="351">Tongji</TOKEN>
<TOKEN id="token-4-12" pos="word" morph="none" start_char="353" end_char="359">Medical</TOKEN>
<TOKEN id="token-4-13" pos="word" morph="none" start_char="361" end_char="367">College</TOKEN>
<TOKEN id="token-4-14" pos="word" morph="none" start_char="369" end_char="371">and</TOKEN>
<TOKEN id="token-4-15" pos="word" morph="none" start_char="373" end_char="380">Huazhong</TOKEN>
<TOKEN id="token-4-16" pos="word" morph="none" start_char="382" end_char="391">University</TOKEN>
<TOKEN id="token-4-17" pos="word" morph="none" start_char="393" end_char="394">of</TOKEN>
<TOKEN id="token-4-18" pos="word" morph="none" start_char="396" end_char="402">Science</TOKEN>
<TOKEN id="token-4-19" pos="word" morph="none" start_char="404" end_char="406">and</TOKEN>
<TOKEN id="token-4-20" pos="word" morph="none" start_char="408" end_char="417">Technology</TOKEN>
<TOKEN id="token-4-21" pos="word" morph="none" start_char="419" end_char="420">in</TOKEN>
<TOKEN id="token-4-22" pos="word" morph="none" start_char="422" end_char="426">Wuhan</TOKEN>
<TOKEN id="token-4-23" pos="punct" morph="none" start_char="427" end_char="427">,</TOKEN>
<TOKEN id="token-4-24" pos="word" morph="none" start_char="429" end_char="433">China</TOKEN>
<TOKEN id="token-4-25" pos="punct" morph="none" start_char="434" end_char="434">,</TOKEN>
<TOKEN id="token-4-26" pos="word" morph="none" start_char="436" end_char="438">and</TOKEN>
<TOKEN id="token-4-27" pos="word" morph="none" start_char="440" end_char="449">colleagues</TOKEN>
<TOKEN id="token-4-28" pos="word" morph="none" start_char="451" end_char="458">describe</TOKEN>
<TOKEN id="token-4-29" pos="word" morph="none" start_char="460" end_char="462">the</TOKEN>
<TOKEN id="token-4-30" pos="word" morph="none" start_char="464" end_char="470">effects</TOKEN>
<TOKEN id="token-4-31" pos="word" morph="none" start_char="472" end_char="473">of</TOKEN>
<TOKEN id="token-4-32" pos="word" morph="none" start_char="475" end_char="483">treatment</TOKEN>
<TOKEN id="token-4-33" pos="word" morph="none" start_char="485" end_char="488">with</TOKEN>
<TOKEN id="token-4-34" pos="unknown" morph="none" start_char="490" end_char="496">IFN-α2b</TOKEN>
<TOKEN id="token-4-35" pos="word" morph="none" start_char="498" end_char="499">in</TOKEN>
<TOKEN id="token-4-36" pos="word" morph="none" start_char="501" end_char="501">a</TOKEN>
<TOKEN id="token-4-37" pos="word" morph="none" start_char="503" end_char="508">cohort</TOKEN>
<TOKEN id="token-4-38" pos="word" morph="none" start_char="510" end_char="511">of</TOKEN>
<TOKEN id="token-4-39" pos="word" morph="none" start_char="513" end_char="514">77</TOKEN>
<TOKEN id="token-4-40" pos="word" morph="none" start_char="516" end_char="521">adults</TOKEN>
<TOKEN id="token-4-41" pos="word" morph="none" start_char="523" end_char="534">hospitalized</TOKEN>
<TOKEN id="token-4-42" pos="word" morph="none" start_char="536" end_char="539">with</TOKEN>
<TOKEN id="token-4-43" pos="word" morph="none" start_char="541" end_char="549">confirmed</TOKEN>
<TOKEN id="token-4-44" pos="unknown" morph="none" start_char="551" end_char="558">COVID-19</TOKEN>
<TOKEN id="token-4-45" pos="punct" morph="none" start_char="559" end_char="559">.</TOKEN>
</SEG>
<SEG id="segment-5" start_char="561" end_char="712">
<ORIGINAL_TEXT>Patients were treated with nebulized IFN-α2b, umifenovir (Arbidol; currently only used in Russia and China) or a combination of IFN-α2b plus umifenovir.</ORIGINAL_TEXT>
<TOKEN id="token-5-0" pos="word" morph="none" start_char="561" end_char="568">Patients</TOKEN>
<TOKEN id="token-5-1" pos="word" morph="none" start_char="570" end_char="573">were</TOKEN>
<TOKEN id="token-5-2" pos="word" morph="none" start_char="575" end_char="581">treated</TOKEN>
<TOKEN id="token-5-3" pos="word" morph="none" start_char="583" end_char="586">with</TOKEN>
<TOKEN id="token-5-4" pos="word" morph="none" start_char="588" end_char="596">nebulized</TOKEN>
<TOKEN id="token-5-5" pos="unknown" morph="none" start_char="598" end_char="604">IFN-α2b</TOKEN>
<TOKEN id="token-5-6" pos="punct" morph="none" start_char="605" end_char="605">,</TOKEN>
<TOKEN id="token-5-7" pos="word" morph="none" start_char="607" end_char="616">umifenovir</TOKEN>
<TOKEN id="token-5-8" pos="punct" morph="none" start_char="618" end_char="618">(</TOKEN>
<TOKEN id="token-5-9" pos="word" morph="none" start_char="619" end_char="625">Arbidol</TOKEN>
<TOKEN id="token-5-10" pos="punct" morph="none" start_char="626" end_char="626">;</TOKEN>
<TOKEN id="token-5-11" pos="word" morph="none" start_char="628" end_char="636">currently</TOKEN>
<TOKEN id="token-5-12" pos="word" morph="none" start_char="638" end_char="641">only</TOKEN>
<TOKEN id="token-5-13" pos="word" morph="none" start_char="643" end_char="646">used</TOKEN>
<TOKEN id="token-5-14" pos="word" morph="none" start_char="648" end_char="649">in</TOKEN>
<TOKEN id="token-5-15" pos="word" morph="none" start_char="651" end_char="656">Russia</TOKEN>
<TOKEN id="token-5-16" pos="word" morph="none" start_char="658" end_char="660">and</TOKEN>
<TOKEN id="token-5-17" pos="word" morph="none" start_char="662" end_char="666">China</TOKEN>
<TOKEN id="token-5-18" pos="punct" morph="none" start_char="667" end_char="667">)</TOKEN>
<TOKEN id="token-5-19" pos="word" morph="none" start_char="669" end_char="670">or</TOKEN>
<TOKEN id="token-5-20" pos="word" morph="none" start_char="672" end_char="672">a</TOKEN>
<TOKEN id="token-5-21" pos="word" morph="none" start_char="674" end_char="684">combination</TOKEN>
<TOKEN id="token-5-22" pos="word" morph="none" start_char="686" end_char="687">of</TOKEN>
<TOKEN id="token-5-23" pos="unknown" morph="none" start_char="689" end_char="695">IFN-α2b</TOKEN>
<TOKEN id="token-5-24" pos="word" morph="none" start_char="697" end_char="700">plus</TOKEN>
<TOKEN id="token-5-25" pos="word" morph="none" start_char="702" end_char="711">umifenovir</TOKEN>
<TOKEN id="token-5-26" pos="punct" morph="none" start_char="712" end_char="712">.</TOKEN>
</SEG>
<SEG id="segment-6" start_char="714" end_char="915">
<ORIGINAL_TEXT>For each patient, serial severe acute respiratory syndrome coronavirus 2 testing along with hematological measurements, temperature, and blood saturation levels were recorded during their hospital stay.</ORIGINAL_TEXT>
<TOKEN id="token-6-0" pos="word" morph="none" start_char="714" end_char="716">For</TOKEN>
<TOKEN id="token-6-1" pos="word" morph="none" start_char="718" end_char="721">each</TOKEN>
<TOKEN id="token-6-2" pos="word" morph="none" start_char="723" end_char="729">patient</TOKEN>
<TOKEN id="token-6-3" pos="punct" morph="none" start_char="730" end_char="730">,</TOKEN>
<TOKEN id="token-6-4" pos="word" morph="none" start_char="732" end_char="737">serial</TOKEN>
<TOKEN id="token-6-5" pos="word" morph="none" start_char="739" end_char="744">severe</TOKEN>
<TOKEN id="token-6-6" pos="word" morph="none" start_char="746" end_char="750">acute</TOKEN>
<TOKEN id="token-6-7" pos="word" morph="none" start_char="752" end_char="762">respiratory</TOKEN>
<TOKEN id="token-6-8" pos="word" morph="none" start_char="764" end_char="771">syndrome</TOKEN>
<TOKEN id="token-6-9" pos="word" morph="none" start_char="773" end_char="783">coronavirus</TOKEN>
<TOKEN id="token-6-10" pos="word" morph="none" start_char="785" end_char="785">2</TOKEN>
<TOKEN id="token-6-11" pos="word" morph="none" start_char="787" end_char="793">testing</TOKEN>
<TOKEN id="token-6-12" pos="word" morph="none" start_char="795" end_char="799">along</TOKEN>
<TOKEN id="token-6-13" pos="word" morph="none" start_char="801" end_char="804">with</TOKEN>
<TOKEN id="token-6-14" pos="word" morph="none" start_char="806" end_char="818">hematological</TOKEN>
<TOKEN id="token-6-15" pos="word" morph="none" start_char="820" end_char="831">measurements</TOKEN>
<TOKEN id="token-6-16" pos="punct" morph="none" start_char="832" end_char="832">,</TOKEN>
<TOKEN id="token-6-17" pos="word" morph="none" start_char="834" end_char="844">temperature</TOKEN>
<TOKEN id="token-6-18" pos="punct" morph="none" start_char="845" end_char="845">,</TOKEN>
<TOKEN id="token-6-19" pos="word" morph="none" start_char="847" end_char="849">and</TOKEN>
<TOKEN id="token-6-20" pos="word" morph="none" start_char="851" end_char="855">blood</TOKEN>
<TOKEN id="token-6-21" pos="word" morph="none" start_char="857" end_char="866">saturation</TOKEN>
<TOKEN id="token-6-22" pos="word" morph="none" start_char="868" end_char="873">levels</TOKEN>
<TOKEN id="token-6-23" pos="word" morph="none" start_char="875" end_char="878">were</TOKEN>
<TOKEN id="token-6-24" pos="word" morph="none" start_char="880" end_char="887">recorded</TOKEN>
<TOKEN id="token-6-25" pos="word" morph="none" start_char="889" end_char="894">during</TOKEN>
<TOKEN id="token-6-26" pos="word" morph="none" start_char="896" end_char="900">their</TOKEN>
<TOKEN id="token-6-27" pos="word" morph="none" start_char="902" end_char="909">hospital</TOKEN>
<TOKEN id="token-6-28" pos="word" morph="none" start_char="911" end_char="914">stay</TOKEN>
<TOKEN id="token-6-29" pos="punct" morph="none" start_char="915" end_char="915">.</TOKEN>
</SEG>
<SEG id="segment-7" start_char="918" end_char="1220">
<ORIGINAL_TEXT>The researchers found that the duration of detectable virus in the upper respiratory tract was significantly reduced with treatment with IFN-α2b with or without umifenovir; in parallel, the duration of elevated blood levels for the inflammatory markers interleukin-6 and C-reactive protein were reduced.</ORIGINAL_TEXT>
<TOKEN id="token-7-0" pos="word" morph="none" start_char="918" end_char="920">The</TOKEN>
<TOKEN id="token-7-1" pos="word" morph="none" start_char="922" end_char="932">researchers</TOKEN>
<TOKEN id="token-7-2" pos="word" morph="none" start_char="934" end_char="938">found</TOKEN>
<TOKEN id="token-7-3" pos="word" morph="none" start_char="940" end_char="943">that</TOKEN>
<TOKEN id="token-7-4" pos="word" morph="none" start_char="945" end_char="947">the</TOKEN>
<TOKEN id="token-7-5" pos="word" morph="none" start_char="949" end_char="956">duration</TOKEN>
<TOKEN id="token-7-6" pos="word" morph="none" start_char="958" end_char="959">of</TOKEN>
<TOKEN id="token-7-7" pos="word" morph="none" start_char="961" end_char="970">detectable</TOKEN>
<TOKEN id="token-7-8" pos="word" morph="none" start_char="972" end_char="976">virus</TOKEN>
<TOKEN id="token-7-9" pos="word" morph="none" start_char="978" end_char="979">in</TOKEN>
<TOKEN id="token-7-10" pos="word" morph="none" start_char="981" end_char="983">the</TOKEN>
<TOKEN id="token-7-11" pos="word" morph="none" start_char="985" end_char="989">upper</TOKEN>
<TOKEN id="token-7-12" pos="word" morph="none" start_char="991" end_char="1001">respiratory</TOKEN>
<TOKEN id="token-7-13" pos="word" morph="none" start_char="1003" end_char="1007">tract</TOKEN>
<TOKEN id="token-7-14" pos="word" morph="none" start_char="1009" end_char="1011">was</TOKEN>
<TOKEN id="token-7-15" pos="word" morph="none" start_char="1013" end_char="1025">significantly</TOKEN>
<TOKEN id="token-7-16" pos="word" morph="none" start_char="1027" end_char="1033">reduced</TOKEN>
<TOKEN id="token-7-17" pos="word" morph="none" start_char="1035" end_char="1038">with</TOKEN>
<TOKEN id="token-7-18" pos="word" morph="none" start_char="1040" end_char="1048">treatment</TOKEN>
<TOKEN id="token-7-19" pos="word" morph="none" start_char="1050" end_char="1053">with</TOKEN>
<TOKEN id="token-7-20" pos="unknown" morph="none" start_char="1055" end_char="1061">IFN-α2b</TOKEN>
<TOKEN id="token-7-21" pos="word" morph="none" start_char="1063" end_char="1066">with</TOKEN>
<TOKEN id="token-7-22" pos="word" morph="none" start_char="1068" end_char="1069">or</TOKEN>
<TOKEN id="token-7-23" pos="word" morph="none" start_char="1071" end_char="1077">without</TOKEN>
<TOKEN id="token-7-24" pos="word" morph="none" start_char="1079" end_char="1088">umifenovir</TOKEN>
<TOKEN id="token-7-25" pos="punct" morph="none" start_char="1089" end_char="1089">;</TOKEN>
<TOKEN id="token-7-26" pos="word" morph="none" start_char="1091" end_char="1092">in</TOKEN>
<TOKEN id="token-7-27" pos="word" morph="none" start_char="1094" end_char="1101">parallel</TOKEN>
<TOKEN id="token-7-28" pos="punct" morph="none" start_char="1102" end_char="1102">,</TOKEN>
<TOKEN id="token-7-29" pos="word" morph="none" start_char="1104" end_char="1106">the</TOKEN>
<TOKEN id="token-7-30" pos="word" morph="none" start_char="1108" end_char="1115">duration</TOKEN>
<TOKEN id="token-7-31" pos="word" morph="none" start_char="1117" end_char="1118">of</TOKEN>
<TOKEN id="token-7-32" pos="word" morph="none" start_char="1120" end_char="1127">elevated</TOKEN>
<TOKEN id="token-7-33" pos="word" morph="none" start_char="1129" end_char="1133">blood</TOKEN>
<TOKEN id="token-7-34" pos="word" morph="none" start_char="1135" end_char="1140">levels</TOKEN>
<TOKEN id="token-7-35" pos="word" morph="none" start_char="1142" end_char="1144">for</TOKEN>
<TOKEN id="token-7-36" pos="word" morph="none" start_char="1146" end_char="1148">the</TOKEN>
<TOKEN id="token-7-37" pos="word" morph="none" start_char="1150" end_char="1161">inflammatory</TOKEN>
<TOKEN id="token-7-38" pos="word" morph="none" start_char="1163" end_char="1169">markers</TOKEN>
<TOKEN id="token-7-39" pos="unknown" morph="none" start_char="1171" end_char="1183">interleukin-6</TOKEN>
<TOKEN id="token-7-40" pos="word" morph="none" start_char="1185" end_char="1187">and</TOKEN>
<TOKEN id="token-7-41" pos="unknown" morph="none" start_char="1189" end_char="1198">C-reactive</TOKEN>
<TOKEN id="token-7-42" pos="word" morph="none" start_char="1200" end_char="1206">protein</TOKEN>
<TOKEN id="token-7-43" pos="word" morph="none" start_char="1208" end_char="1211">were</TOKEN>
<TOKEN id="token-7-44" pos="word" morph="none" start_char="1213" end_char="1219">reduced</TOKEN>
<TOKEN id="token-7-45" pos="punct" morph="none" start_char="1220" end_char="1220">.</TOKEN>
</SEG>
<SEG id="segment-8" start_char="1223" end_char="1403">
<ORIGINAL_TEXT>"To our knowledge, the findings presented here are the first to suggest therapeutic efficacy in COVID-19 disease of IFN-α2b, an available antiviral intervention," the authors write.</ORIGINAL_TEXT>
<TOKEN id="token-8-0" pos="punct" morph="none" start_char="1223" end_char="1223">"</TOKEN>
<TOKEN id="token-8-1" pos="word" morph="none" start_char="1224" end_char="1225">To</TOKEN>
<TOKEN id="token-8-2" pos="word" morph="none" start_char="1227" end_char="1229">our</TOKEN>
<TOKEN id="token-8-3" pos="word" morph="none" start_char="1231" end_char="1239">knowledge</TOKEN>
<TOKEN id="token-8-4" pos="punct" morph="none" start_char="1240" end_char="1240">,</TOKEN>
<TOKEN id="token-8-5" pos="word" morph="none" start_char="1242" end_char="1244">the</TOKEN>
<TOKEN id="token-8-6" pos="word" morph="none" start_char="1246" end_char="1253">findings</TOKEN>
<TOKEN id="token-8-7" pos="word" morph="none" start_char="1255" end_char="1263">presented</TOKEN>
<TOKEN id="token-8-8" pos="word" morph="none" start_char="1265" end_char="1268">here</TOKEN>
<TOKEN id="token-8-9" pos="word" morph="none" start_char="1270" end_char="1272">are</TOKEN>
<TOKEN id="token-8-10" pos="word" morph="none" start_char="1274" end_char="1276">the</TOKEN>
<TOKEN id="token-8-11" pos="word" morph="none" start_char="1278" end_char="1282">first</TOKEN>
<TOKEN id="token-8-12" pos="word" morph="none" start_char="1284" end_char="1285">to</TOKEN>
<TOKEN id="token-8-13" pos="word" morph="none" start_char="1287" end_char="1293">suggest</TOKEN>
<TOKEN id="token-8-14" pos="word" morph="none" start_char="1295" end_char="1305">therapeutic</TOKEN>
<TOKEN id="token-8-15" pos="word" morph="none" start_char="1307" end_char="1314">efficacy</TOKEN>
<TOKEN id="token-8-16" pos="word" morph="none" start_char="1316" end_char="1317">in</TOKEN>
<TOKEN id="token-8-17" pos="unknown" morph="none" start_char="1319" end_char="1326">COVID-19</TOKEN>
<TOKEN id="token-8-18" pos="word" morph="none" start_char="1328" end_char="1334">disease</TOKEN>
<TOKEN id="token-8-19" pos="word" morph="none" start_char="1336" end_char="1337">of</TOKEN>
<TOKEN id="token-8-20" pos="unknown" morph="none" start_char="1339" end_char="1345">IFN-α2b</TOKEN>
<TOKEN id="token-8-21" pos="punct" morph="none" start_char="1346" end_char="1346">,</TOKEN>
<TOKEN id="token-8-22" pos="word" morph="none" start_char="1348" end_char="1349">an</TOKEN>
<TOKEN id="token-8-23" pos="word" morph="none" start_char="1351" end_char="1359">available</TOKEN>
<TOKEN id="token-8-24" pos="word" morph="none" start_char="1361" end_char="1369">antiviral</TOKEN>
<TOKEN id="token-8-25" pos="word" morph="none" start_char="1371" end_char="1382">intervention</TOKEN>
<TOKEN id="token-8-26" pos="punct" morph="none" start_char="1383" end_char="1384">,"</TOKEN>
<TOKEN id="token-8-27" pos="word" morph="none" start_char="1386" end_char="1388">the</TOKEN>
<TOKEN id="token-8-28" pos="word" morph="none" start_char="1390" end_char="1396">authors</TOKEN>
<TOKEN id="token-8-29" pos="word" morph="none" start_char="1398" end_char="1402">write</TOKEN>
<TOKEN id="token-8-30" pos="punct" morph="none" start_char="1403" end_char="1403">.</TOKEN>
</SEG>
<SEG id="segment-9" start_char="1405" end_char="1617">
<ORIGINAL_TEXT>"Beyond clinical benefit to the individual patient, treatment with IFN-α2b may also benefit public health measures aimed at slowing the tide of this pandemic, in that duration of viral shedding appears shortened."</ORIGINAL_TEXT>
<TOKEN id="token-9-0" pos="punct" morph="none" start_char="1405" end_char="1405">"</TOKEN>
<TOKEN id="token-9-1" pos="word" morph="none" start_char="1406" end_char="1411">Beyond</TOKEN>
<TOKEN id="token-9-2" pos="word" morph="none" start_char="1413" end_char="1420">clinical</TOKEN>
<TOKEN id="token-9-3" pos="word" morph="none" start_char="1422" end_char="1428">benefit</TOKEN>
<TOKEN id="token-9-4" pos="word" morph="none" start_char="1430" end_char="1431">to</TOKEN>
<TOKEN id="token-9-5" pos="word" morph="none" start_char="1433" end_char="1435">the</TOKEN>
<TOKEN id="token-9-6" pos="word" morph="none" start_char="1437" end_char="1446">individual</TOKEN>
<TOKEN id="token-9-7" pos="word" morph="none" start_char="1448" end_char="1454">patient</TOKEN>
<TOKEN id="token-9-8" pos="punct" morph="none" start_char="1455" end_char="1455">,</TOKEN>
<TOKEN id="token-9-9" pos="word" morph="none" start_char="1457" end_char="1465">treatment</TOKEN>
<TOKEN id="token-9-10" pos="word" morph="none" start_char="1467" end_char="1470">with</TOKEN>
<TOKEN id="token-9-11" pos="unknown" morph="none" start_char="1472" end_char="1478">IFN-α2b</TOKEN>
<TOKEN id="token-9-12" pos="word" morph="none" start_char="1480" end_char="1482">may</TOKEN>
<TOKEN id="token-9-13" pos="word" morph="none" start_char="1484" end_char="1487">also</TOKEN>
<TOKEN id="token-9-14" pos="word" morph="none" start_char="1489" end_char="1495">benefit</TOKEN>
<TOKEN id="token-9-15" pos="word" morph="none" start_char="1497" end_char="1502">public</TOKEN>
<TOKEN id="token-9-16" pos="word" morph="none" start_char="1504" end_char="1509">health</TOKEN>
<TOKEN id="token-9-17" pos="word" morph="none" start_char="1511" end_char="1518">measures</TOKEN>
<TOKEN id="token-9-18" pos="word" morph="none" start_char="1520" end_char="1524">aimed</TOKEN>
<TOKEN id="token-9-19" pos="word" morph="none" start_char="1526" end_char="1527">at</TOKEN>
<TOKEN id="token-9-20" pos="word" morph="none" start_char="1529" end_char="1535">slowing</TOKEN>
<TOKEN id="token-9-21" pos="word" morph="none" start_char="1537" end_char="1539">the</TOKEN>
<TOKEN id="token-9-22" pos="word" morph="none" start_char="1541" end_char="1544">tide</TOKEN>
<TOKEN id="token-9-23" pos="word" morph="none" start_char="1546" end_char="1547">of</TOKEN>
<TOKEN id="token-9-24" pos="word" morph="none" start_char="1549" end_char="1552">this</TOKEN>
<TOKEN id="token-9-25" pos="word" morph="none" start_char="1554" end_char="1561">pandemic</TOKEN>
<TOKEN id="token-9-26" pos="punct" morph="none" start_char="1562" end_char="1562">,</TOKEN>
<TOKEN id="token-9-27" pos="word" morph="none" start_char="1564" end_char="1565">in</TOKEN>
<TOKEN id="token-9-28" pos="word" morph="none" start_char="1567" end_char="1570">that</TOKEN>
<TOKEN id="token-9-29" pos="word" morph="none" start_char="1572" end_char="1579">duration</TOKEN>
<TOKEN id="token-9-30" pos="word" morph="none" start_char="1581" end_char="1582">of</TOKEN>
<TOKEN id="token-9-31" pos="word" morph="none" start_char="1584" end_char="1588">viral</TOKEN>
<TOKEN id="token-9-32" pos="word" morph="none" start_char="1590" end_char="1597">shedding</TOKEN>
<TOKEN id="token-9-33" pos="word" morph="none" start_char="1599" end_char="1605">appears</TOKEN>
<TOKEN id="token-9-34" pos="word" morph="none" start_char="1607" end_char="1615">shortened</TOKEN>
<TOKEN id="token-9-35" pos="punct" morph="none" start_char="1616" end_char="1617">."</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>
